The pursuit of innovative therapies for genetic diseases hinges on the availability of highly specialized chemical compounds that enable targeted research. VX-661 (CAS 1152311-62-0) stands out as a critical CFTR corrector, essential for scientists investigating conditions like cystic fibrosis. As a leading manufacturer and supplier of this advanced pharmaceutical intermediate, we are dedicated to equipping the research community with the high-quality VX-661 needed for significant scientific breakthroughs.

At its core, VX-661 is designed to address the challenges posed by the F508del mutation in the CFTR gene. This mutation results in a protein that misfolds and fails to reach its proper functional location within the cell. VX-661 acts as a molecular chaperone, facilitating the correct folding and transport of the CFTR protein to the cell surface. This mechanism is crucial for restoring ion channel function and is the subject of extensive research in the development of new treatments for cystic fibrosis. Understanding this role is key for anyone looking to buy VX-661 for their research.

Our commitment as a VX-661 manufacturer in China is to provide a product that meets the stringent demands of scientific inquiry. We ensure exceptional purity, often exceeding 99%, through rigorous quality control processes, including advanced analytical techniques. This high standard is vital for ensuring the accuracy and reliability of experimental data. Researchers can therefore be confident in the performance of our VX-661 when conducting in vitro studies, cellular assays, and preclinical investigations.

For those seeking to procure VX-661, understanding the available supply channels is important. We operate as a direct supplier, enabling us to offer competitive pricing. This accessibility is crucial for research projects that may have limited budgets but require potent and reliable compounds. We encourage potential clients to inquire about the price of VX-661 and explore our flexible purchasing options. As a global supplier, we are equipped to handle orders of varying scales.

The scientific literature increasingly highlights the importance of VX-661 in combination therapies and its role in advancing our understanding of CFTR function. Its utility extends to various stages of drug discovery, from target validation to preclinical efficacy studies. By providing a consistent and dependable source for this essential compound, we aim to accelerate the pace of research in this critical area. The CAS number 1152311-62-0 is the definitive identifier for the high-quality VX-661 we supply.

In conclusion, for researchers requiring VX-661 (CAS 1152311-62-0) for their groundbreaking work, partnering with an experienced and quality-focused manufacturer and supplier is essential. Our operations in China are geared towards providing this vital CFTR corrector with the purity and affordability that modern research demands. Contact us to discuss your requirements, request a quote, and secure a reliable supply of VX-661 for your scientific explorations.